The Adelaide biotech, founded in 2016, uses magnetic nanoparticles for better cancer detection during surgery. The Series A began in 2020.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback